Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • autoantibodies (2)
  • F18 (2)
  • female (1)
  • GABA B (2)
  • gabab (6)
  • humans (1)
  • patients (5)
  • positron (3)
  • prognosis (5)
  • radiopharmaceuticals (2)
  • receptor (6)
  • receptors gaba- b (2)
  • Sizes of these terms reflect their relevance to your search.

    To identify the metabolic pattern and prognostic predictors in anti-gamma-aminobutyric-acid B (GABAB) receptor encephalitis using 18 F-fluorodeoxy-glucose positron emission tomography (18 F-FDG-PET). Twenty-one patients diagnosed anti-GABAB receptor encephalitis who underwent 18 F-FDG-PET at first hospitalization were retrospectively reviewed. 18 F-FDG-PET images were analyzed in comparison with controls. Further group comparisons of 18 F-FDG-PET data were carried out between prognostic subgroups. 18 F-FDG-PET was abnormal in 81% patients with anti-GABAB receptor encephalitis and was more sensitive than MRI (81% vs. 42.9%, p = 0.025). Alter limbic lobe glucose metabolism (mostly hypermetabolism) was observed in 14 patients (66.7%), of whom 10 (10/14, 71.4%) demonstrated hypermetabolism in the medial temporal lobe (MTL). Group analysis also confirmed MTL hypermetabolism in association with relative frontal and parietal hypometabolism was a general metabolic pattern. After a median follow-up of 33 months, the group comparisons revealed that patients with poor outcome demonstrated increased metabolism in the MTL compared to those with good outcome. 18 F-FDG-PET may be more sensitive than MRI in the early diagnosis of anti-GABAB receptor encephalitis. MTL hypermetabolism was associated with relative frontal or parietal hypometabolism and may serve as a prognostic biomarker in anti-GABAB receptor encephalitis. © 2021 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.


    Xiao Liu, Tingting Yu, Xiaobin Zhao, Gongfei Li, Ruijuan Lv, Lin Ai, Qun Wang. 18 F-fluorodeoxy-glucose positron emission tomography pattern and prognostic predictors in patients with anti-GABAB receptor encephalitis. CNS neuroscience & therapeutics. 2022 Feb;28(2):269-278

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34837479

    View Full Text